Received Apr 27, 2026
Reports are unverified and do not show that a vaccine caused an event. Full disclaimer
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | UNK | — |
significant swelling at injection site at 3 hours; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of injection site swelling in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received Shingles vaccine. On an unknown date, 30 hrs after receiving Shingles vaccine, the patient experienced injection site swelling (Verbatim: significant swelling at injection site at 3 hours). The outcome of the injection site swelling was not reported. It was unknown if the reporter considered the injection site swelling to be related to Shingles vaccine. It was unknown if the company considered the injection site swelling to be related to Shingles vaccine. Additional Information: GSK Receipt Date: 08-APR-2026 The batch number was not provided, and we are unable to contact the reporter.